With pharmaceutical experience and an impressive decade-long career in the cannabis and hemp sector, Darcie is a well-rounded expert in ensuring top-notch quality standards. Her extensive knowledge spans seed to sale, cultivation, extraction, testing, quality assurance, compliance, and pharmaceutical practices. Darcie's diverse background allows her to bring a unique perspective to her role at Vantage.
In addition to her expertise in quality management, Darcie has showcased her knowledge and skills in pharmaceutical audits and as a result, has positioned Vantage as a trusted and reliable partner for pharmaceutical and clinical study customers.
Darcie also played a pivotal role in developing Vantage's Quality Management System (QMS) and has successfully scaled it to an electronic system. Through her innovative thinking and expertise, she has introduced enhancements like automation, streamlining the company’s processes.
Darcie's contributions to the cannabis and hemp industry extend beyond her role at Vantage. As a member of the ASTM subcommittee for D37.02 Cannabis and Hemp Quality Management Systems, she actively shapes the future of quality standards in the industry. Her expertise and commitment to quality make her an invaluable asset to the committee and the industry as a whole.
Leading producer’s compliance with stringent regulatory requirements drives global expansion Greeley, Colorado, September 21, 2023 – Vantage Hemp Co. (“Vantage” or the “Company”) announces the completion of a rigorous four-day audit conducted by Australia’s Therapeutic Goods Administration (TGA), the country’s...
With the growing trend of plant-based wellness, individuals are redefining their approach to health, seeking natural remedies and plant-derived products. One unique plant stands out for its rich history and diverse applications – Oleander. Scientifically known as Nerium oleander, the...
The 5 P's of GMP — people, premises, processes, products and procedures.
Vantage Hemp Co. has become a global leader in the production of CBD oil and isolates by meeting ICH Q7 and WHO GMP standards for the industry.
Establishing a regulatory framework for CBD, consumer safety, production quality, the 2022 omnibus spending bill, and Vantage's DMF filing.
Dive into the establishment of US hemp policy and the importance of selecting a pharmaceutically proficient CBD extractor and contract manufacturer.